                         SEQUENCE LISTING

<110>  The Institute of Organic Chemistry and Biochemistry AS CR
       Spyder Institute Praha, s.r.o.
 
<120>  Device for parallel oligomer synthesis, method of parallel 
       oligomer synthesis and use thereof

<130>  XXX

<160>  25    

<170>  PatentIn version 3.5

<210>  1
<211>  5
<212>  PRT
<213>  artificial

<220>
<223>  artificial peptide synthesis

<400>  1

Tyr Gly Gly Phe Leu 
1               5   


<210>  2
<211>  5
<212>  PRT
<213>  artificial

<220>
<223>  artificial peptide synthesis

<400>  2

Gly Gly Tyr Phe Leu 
1               5   


<210>  3
<211>  5
<212>  PRT
<213>  artificial

<220>
<223>  artificial peptide synthesis

<400>  3

Gly Gly Tyr Leu Phe 
1               5   


<210>  4
<211>  5
<212>  PRT
<213>  artificial

<220>
<223>  artificial peptide synthesis

<400>  4

Gly Gly Phe Tyr Leu 
1               5   


<210>  5
<211>  5
<212>  PRT
<213>  artificial

<220>
<223>  artificial peptide synthesis

<400>  5

Gly Gly Phe Leu Tyr 
1               5   


<210>  6
<211>  5
<212>  PRT
<213>  artificial

<220>
<223>  artificial peptide synthesis

<400>  6

Gly Gly Leu Tyr Phe 
1               5   


<210>  7
<211>  5
<212>  PRT
<213>  artificial

<220>
<223>  artificial peptide synthesis

<400>  7

Gly Gly Leu Phe Tyr 
1               5   


<210>  8
<211>  5
<212>  PRT
<213>  artificial

<220>
<223>  artificial peptide synthesis

<400>  8

Gly Tyr Gly Phe Leu 
1               5   


<210>  9
<211>  5
<212>  PRT
<213>  artificial

<220>
<223>  artificial peptide synthesis

<400>  9

Gly Tyr Gly Leu Phe 
1               5   


<210>  10
<211>  5
<212>  PRT
<213>  artificial

<220>
<223>  artificial peptide synthesis

<400>  10

Gly Tyr Phe Gly Leu 
1               5   


<210>  11
<211>  5
<212>  PRT
<213>  artificial

<220>
<223>  artificial peptide synthesis

<400>  11

Gly Tyr Phe Leu Gly 
1               5   


<210>  12
<211>  5
<212>  PRT
<213>  artificial

<220>
<223>  artificial peptide synthesis

<400>  12

Gly Tyr Leu Gly Phe 
1               5   


<210>  13
<211>  5
<212>  PRT
<213>  artificial

<220>
<223>  artificial peptide synthesis

<400>  13

Gly Tyr Leu Phe Gly 
1               5   


<210>  14
<211>  5
<212>  PRT
<213>  artificial

<220>
<223>  artificial peptide synthesis

<400>  14

Gly Phe Gly Tyr Leu 
1               5   


<210>  15
<211>  5
<212>  PRT
<213>  artificial

<220>
<223>  artificial peptide synthesis

<400>  15

Gly Phe Gly Leu Tyr 
1               5   


<210>  16
<211>  5
<212>  PRT
<213>  artificial

<220>
<223>  artificial peptide synthesis

<400>  16

Gly Phe Tyr Gly Leu 
1               5   


<210>  17
<211>  5
<212>  PRT
<213>  artificial

<220>
<223>  artificial peptide synthesis

<400>  17

Gly Phe Tyr Leu Gly 
1               5   


<210>  18
<211>  5
<212>  PRT
<213>  artificial

<220>
<223>  artificial peptide synthesis

<400>  18

Gly Phe Leu Gly Tyr 
1               5   


<210>  19
<211>  5
<212>  PRT
<213>  artificial

<220>
<223>  artificial peptide synthesis

<400>  19

Gly Phe Leu Tyr Gly 
1               5   


<210>  20
<211>  5
<212>  PRT
<213>  artificial

<220>
<223>  artificial peptide synthesis

<400>  20

Gly Leu Gly Tyr Phe 
1               5   


<210>  21
<211>  5
<212>  PRT
<213>  artificial

<220>
<223>  artificial peptide synthesis

<400>  21

Gly Leu Gly Phe Tyr 
1               5   


<210>  22
<211>  5
<212>  PRT
<213>  artificial

<220>
<223>  artificial peptide synthesis

<400>  22

Gly Leu Tyr Gly Phe 
1               5   


<210>  23
<211>  5
<212>  PRT
<213>  artificial

<220>
<223>  artificial peptide synthesis

<400>  23

Gly Leu Tyr Phe Gly 
1               5   


<210>  24
<211>  5
<212>  PRT
<213>  artificial

<220>
<223>  artificial peptide synthesis

<400>  24

Tyr Gly Gly Phe Leu 
1               5   


<210>  25
<211>  24
<212>  PRT
<213>  artificial

<220>
<223>  artificial peptide synthesis


<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  SSO3H

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  SSO3H

<220>
<221>  MISC_FEATURE
<222>  (23)..(23)
<223>  SSO3H

<400>  25

Gly Ile Val Glu Gln Cys Xaa Cys Thr Ser Ile Cys Xaa Ser Leu Tyr 
1               5                   10                  15      


Gln Leu Glu Asn Tyr Cys Xaa Asn 
            20                  


